CST
JNJ icon

Charles Schwab Trust’s Johnson & Johnson JNJ Stock Holding History

Charles Schwab Trust’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.92M Buy
15,446
+2,027
+15% +$472K 0.22% 53
2026
Q1 		$3.28M Sell
13,419
-2,706
-17% -$630K 0.21% 54
2025
Q4 		$3.34M Buy
16,125
+334
+2% +$66K 0.22% 54
2025
Q3 		$2.93M Buy
15,791
+609
+4% +$104K 0.2% 59
2025
Q2 		$2.32M Hold
15,182
– – 0.17% 64
2025
Q1 		$2.52M Buy
15,182
+282
+2% +$44.1K 0.21% 55
2024
Q4 		$2.15M Sell
14,900
-15
-0.1% -$2.32K 0.19% 60
2024
Q3 		$2.42M Sell
14,915
-3,941
-21% -$628K 0.21% 60
2024
Q2 		$2.76M Sell
18,856
-609
-3% -$90.6K 0.26% 53
2024
Q1 		$3.08M Sell
19,465
-1,315
-6% -$209K 0.29% 47
2023
Q4 		$3.26M Sell
20,780
-1,001
-5% -$153K 0.32% 47
2023
Q3 		$3.39M Buy
21,781
+6,941
+47% +$1.15M 0.38% 46
2023
Q2 		$2.3M Sell
14,840
-292
-2% -$47.1K 0.28% 47
2023
Q1 		$2.35M Sell
15,132
-8,444
-36% -$1.36M 0.28% 46
2022
Q4 		$4.16M Buy
23,576
+1,771
+8% +$306K 0.55% 37
2022
Q3 		$3.56M Sell
21,805
-888
-4% -$150K 0.6% 31
2022
Q2 		$4.03M Buy
22,693
+87
+0.4% +$15.5K 0.83% 21
2022
Q1 		$4.01M Sell
22,606
-1,385
-6% -$236K 0.7% 24
2021
Q4 		$4.1M Buy
23,991
+217
+0.9% +$35.5K 0.67% 26
2021
Q3 		$3.84M Buy
23,774
+734
+3% +$125K 0.75% 33
2021
Q2 		$3.8M Sell
23,040
-239
-1% -$39.6K 0.75% 33
2021
Q1 		$3.79M Sell
23,279
-2,572
-10% -$416K 0.79% 33
2020
Q4 		$4.07M Hold
25,851
– – 0.98% 28
2020
Q3 		$3.85M Buy
25,851
+612
+2% +$90.6K 1.18% 25
2020
Q2 		$3.55M Sell
25,239
-3,127
-11% -$456K 1.18% 24
2020
Q1 		$3.72M Buy
28,366
+5,575
+24% +$791K 1.54% 20
2019
Q4 		$3.33M Buy
22,791
+11,469
+101% +$1.56M 1.29% 20
2019
Q3 		$1.47M Buy
+11,322
New +$1.49M 0.69% 48

Other funds holding JNJ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab Trust's JNJ Position: Q2 2026 in Review

Charles Schwab Trust increased its Johnson & Johnson (JNJ) stake by 15% in Q2 2026, buying an estimated $472K and bringing the position to 15,446 shares worth $3.92M. The position accounts for 0.22% of the portfolio, ranked #53.

Charles Schwab Trust first reported a position in JNJ in Q3 2019 and has held it in 28 quarters since. The position peaked at $4.16M in Q4 2022. 4,160 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Charles Schwab Trust held 15,446 shares of Johnson & Johnson worth $3.92M as of Q2 2026.
  • Charles Schwab Trust bought 2,027 Johnson & Johnson shares in Q2 2026, an estimated $472K.
  • Johnson & Johnson made up 0.22% of Charles Schwab Trust's portfolio in Q2 2026, its #53 holding.
  • Charles Schwab Trust first reported a position in Johnson & Johnson in Q3 2019 and has held it in 28 quarters since.
  • Charles Schwab Trust's Johnson & Johnson position peaked at $4.16M in Q4 2022.
  • 4,160 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Charles Schwab Trust's 13F filing for Q2 2026, filed 10 Jul 2026.